Literature DB >> 20202456

Two lineages of dengue virus type 2, Brazil.

Michelli Faria Oliveira, Joselio Maria Galvao Araujo, Orlando Costa Ferreira, Davis Fernandes Ferreira, Dirce Bonfim Lima, Flavia Barreto Santos, Hermann Goncalves Schatzmayr, Amilcar Tanuri, Rita Maria Ribeiro Nogueira.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20202456      PMCID: PMC3322019          DOI: 10.3201/eid1603.090996

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Dengue viruses (DENVs) belong to the genus Flavivirus (family Flaviviridae) and exist as 4 antigenic types, serotypes 1–4, each with well-defined genotypes. Dengue virus is associated with clinical manifestations that range from asymptomatic infections and relatively mild disease (classic dengue fever) to more severe forms of dengue hemorrhagic fever and dengue shock syndrome. Dengue has become one of the most serious vector-borne diseases in humans. The World Health Organization estimates that 2.5 billion persons live in dengue-endemic areas and >50 million are infected annually (). In 1986, dengue virus type 1 (DENV-1) caused an outbreak in the state of Rio de Janeiro and has since become a public health concern and threat in Brazil. (). In 1990, DENV-2 was reported in the state of Rio de Janeiro, where the first severe forms of dengue hemorrhagic fever and fatal cases of dengue shock syndrome were documented. The disease gradually spread to other regions of the country (). In 2002, DENV-3 caused the most severe dengue outbreak in the country and sporadic outbreaks continued to be documented through 2005 (). Since 1990, two additional epidemics caused by DENV-2 have occurred (1998 and 2007–2008) in Brazil. A severe DENV-2 epidemic in the state of Rio de Janeiro began in 2007 and continued in 2008; a total of 255,818 cases and 252 deaths were reported (). This epidemic prompted us to investigate the genetic relatedness of DENV-2 for all of these epidemics. DENV-2 isolates from these epidemic periods were subjected to sequencing and comparison. Gross sequences of DENV-2 isolates from all epidemic periods grouped with sequences from DENV-2 American/Asian genotype; this finding was expected because this genotype is circulating in the Americas (,). Sequences of DENV-2 isolates from the 1998 epidemic grouped with sequences of DENV-2 isolates from the 1990 epidemic (data not shown) suggesting that viruses circulating during these 2 epidemic periods belong to the same lineage of the DENV-2 strain originally found in the state of Rio de Janeiro. However, sequences of DENV-2 isolates from 2007/2008 epidemics grouped separately and distinctly from the 1990 and 1998 DENV-2 isolates and represented a monophyletic group in the phylogenetic tree with bootstraps of 98% (Figure). This result shows a temporal circulation of genetically different viruses in Rio de Janeiro that could be a result of local evolution of DENV-2 since its introduction in 1990, or even an introduction of a new lineage of DENV-2 in the region.
Figure

Neighbor-joining phylogenetic tree of 68 complete envelope (E) gene sequences of dengue virus type 2 (DENV-2). Only bootstrap values >80% are shown. DENV-2 sequences obtained from 21 patients infected during the 1990, 1998, and 2007–2008 epidemics were isolated from acute-phase cases. Viral RNA was extracted from 140 µL of serum or supernatant of infected C636 cell cultures by using the QIAamp Viral RNA Mini Kit (QIAGEN, Valencia, CA, USA), and cDNA synthesis was performed by using the ThermoScript reverse transcription–PCR System (Invitrogen, Carlsbad, CA, USA) according to the manufacturers’ recommendations. We obtained a fragment of 1,878 bp with the complete dengue virus envelope (E) gene sequence by seminested PCR using Taq Platinum DNA polymerase (Invitrogen). The PCR products were purified by using the Millipore (Billerica, MA, USA) purification column and sequenced by using BigDye Terminator version 3.1 Cycle Sequencing (Applied Biosystems, Foster City, CA, USA) and ABI3130 automated sequencer. Sequences of the E gene were compared with DENV-2 sequences of American/Asian genotype deposited in GenBank (www.ncbi.nlm.nih.gov). Strains of Asian genotype I served as the outgroup. All sequences were aligned by using ClustalX (www.ebi.ac.uk/clustalw), and phylogenetic analysis was performed by using MEGA 4.0 (www.megasoftware.net), according to the Tamura-Nei model. First, neighbor-joining trees were constructed by using a 798 pb of the at 5′ region of the E gene and later trees were constructed with sequences from the 1998, and 2007–2008 epidemics by using the complete E gene sequence (1,485 bp). The reliability of the inferred phylogenetic tree was estimated by the bootstrap method, with 1,000 replications. Horizontal branch lengths are drawn to scale, and the tree was rooted by using the Asian genotype, which always appears as the most divergent. Scale bar represents percentage of genetic distance. The names of DENV-2 isolates include reference to year of isolation and country of origin: BR, Brazil; CO, Colombia; DO, Dominican Republic; EC, Ecuador; PR, Puerto Rico; PY, Paraguay; TH, Thailand; VE, Venezuela. GenBank accession nos: 1990/BR/39537 (GQ368156); 1990/BR/40044 (GQ368157); 1998/BR/63415 (GQ368158); 1998/BR/63428 (GQ368159); 1998/BR/63205 (GQ368160); 2007/BR/86977 (GQ368161); 2007/BR/87183 (GQ368162); 2007/BR/87730 (GQ368163); 2007/BR/88034 (GQ368164); 2008/BR/030 (GQ368165); 2008/BR/246 (GQ368166); 2008/BR/258 (GQ368167); 2008/BR/303 (GQ368168); 2008/BR/305 (GQ368169); 2008/BR/312 (GQ368170); 2008/BR/316–08 (GQ368171); 2008/BR/337–08 (GQ368172); 1998/BR/63444 (GQ368173); 1998/BR/64020 (GQ368174); 2008/BR/T2 (GQ368175); 2008/BR/T1 (GQ368176).

Neighbor-joining phylogenetic tree of 68 complete envelope (E) gene sequences of dengue virus type 2 (DENV-2). Only bootstrap values >80% are shown. DENV-2 sequences obtained from 21 patients infected during the 1990, 1998, and 2007–2008 epidemics were isolated from acute-phase cases. Viral RNA was extracted from 140 µL of serum or supernatant of infected C636 cell cultures by using the QIAamp Viral RNA Mini Kit (QIAGEN, Valencia, CA, USA), and cDNA synthesis was performed by using the ThermoScript reverse transcription–PCR System (Invitrogen, Carlsbad, CA, USA) according to the manufacturers’ recommendations. We obtained a fragment of 1,878 bp with the complete dengue virus envelope (E) gene sequence by seminested PCR using Taq Platinum DNA polymerase (Invitrogen). The PCR products were purified by using the Millipore (Billerica, MA, USA) purification column and sequenced by using BigDye Terminator version 3.1 Cycle Sequencing (Applied Biosystems, Foster City, CA, USA) and ABI3130 automated sequencer. Sequences of the E gene were compared with DENV-2 sequences of American/Asian genotype deposited in GenBank (www.ncbi.nlm.nih.gov). Strains of Asian genotype I served as the outgroup. All sequences were aligned by using ClustalX (www.ebi.ac.uk/clustalw), and phylogenetic analysis was performed by using MEGA 4.0 (www.megasoftware.net), according to the Tamura-Nei model. First, neighbor-joining trees were constructed by using a 798 pb of the at 5′ region of the E gene and later trees were constructed with sequences from the 1998, and 2007–2008 epidemics by using the complete E gene sequence (1,485 bp). The reliability of the inferred phylogenetic tree was estimated by the bootstrap method, with 1,000 replications. Horizontal branch lengths are drawn to scale, and the tree was rooted by using the Asian genotype, which always appears as the most divergent. Scale bar represents percentage of genetic distance. The names of DENV-2 isolates include reference to year of isolation and country of origin: BR, Brazil; CO, Colombia; DO, Dominican Republic; EC, Ecuador; PR, Puerto Rico; PY, Paraguay; TH, Thailand; VE, Venezuela. GenBank accession nos: 1990/BR/39537 (GQ368156); 1990/BR/40044 (GQ368157); 1998/BR/63415 (GQ368158); 1998/BR/63428 (GQ368159); 1998/BR/63205 (GQ368160); 2007/BR/86977 (GQ368161); 2007/BR/87183 (GQ368162); 2007/BR/87730 (GQ368163); 2007/BR/88034 (GQ368164); 2008/BR/030 (GQ368165); 2008/BR/246 (GQ368166); 2008/BR/258 (GQ368167); 2008/BR/303 (GQ368168); 2008/BR/305 (GQ368169); 2008/BR/312 (GQ368170); 2008/BR/316–08 (GQ368171); 2008/BR/337–08 (GQ368172); 1998/BR/63444 (GQ368173); 1998/BR/64020 (GQ368174); 2008/BR/T2 (GQ368175); 2008/BR/T1 (GQ368176). A study conducted by Aquino et al. () showed that Paraguayan DENV-2 strains could be grouped as 2 distinct variants within the American/Asian genotype, thus further supporting that the introduction of new DENV-2 variants may likely associate with the shift of dominant serotypes from DENV-3 to DENV-2 in 2005 and might have caused an outbreak of DENV-2. Our results are consistent with this scenario because was a shift of a dominant serotype from DENV-3 to DENV-2 that was observed in 2008 in Rio de Janeiro. However, other factors, such as immunity level to DENV-3 and DENV-2, could explain the shift of dominant serotype besides the circulation of a new viral variant. Because the dengue outbreaks of 2007 and 2008 were the most severe of the dengue infections in Brazil in terms of number of cases and deaths, this genetically distinct DENV-2 could have contributed to this pathogenic profile. Additionally, these samples came from disperse locations in Rio de Janeiro and we do not believe that there is a clustering issue in our sampling. However, again, other factors must be considered as contributors to this scenario because of the intrinsic properties of this distinct virus, host susceptibility, and secondary cases of infection. In addition, detailed examination of amino acid sequences of Brazilian DENV-2 strains isolated in 1998 and 2008 showed 6 aa substitutions in the envelope gene: V129I, L131Q, I170T, E203D, M340T, and I380V. Our results support the notion that aa positions at 129 and 131 in the envelope gene are critical genetic markers for phylogenetic classification of DENV-2 (–). Notably, residue 131 in the envelope gene is located within a pH-dependent hinge region at the interface between domains I and II of the envelope protein. Mutations at this region may affect the pH threshold of fusion and the process of conformational changes (). Our results suggest the circulation of genetically different DENV-2 in Brazil and that these viruses may have a role in severity of dengue diseases. These findings can help to further understand the complex dynamic pathogenic profile of dengue viruses and their circulation in dengue-endemic regions.
  8 in total

1.  Molecular evolution of dengue 2 virus in Puerto Rico: positive selection in the viral envelope accompanies clade reintroduction.

Authors:  Shannon N Bennett; Edward C Holmes; Maritza Chirivella; Dania M Rodriguez; Manuela Beltran; Vance Vorndam; Duane J Gubler; W Owen McMillan
Journal:  J Gen Virol       Date:  2006-04       Impact factor: 3.891

2.  Dengue epidemic in the stage of Rio de Janeiro, Brazil, 1990-1: co-circulation of dengue 1 and dengue 2 serotypes.

Authors:  R M Nogueira; M P Miagostovich; E Lampe; R W Souza; S M Zagne; H G Schatzmayr
Journal:  Epidemiol Infect       Date:  1993-08       Impact factor: 2.451

3.  Molecular epidemiology of dengue virus serotypes 2 and 3 in Paraguay during 2001-2006: the association of viral clade introductions with shifting serotype dominance.

Authors:  Jose D J Diaz Aquino; Wei-Feng Tang; Ryoichi Ishii; Tetsuro Ono; Yuki Eshita; Hiroshi Aono; Yoshihiro Makino
Journal:  Virus Res       Date:  2008-08-23       Impact factor: 3.303

4.  Structure of the dengue virus envelope protein after membrane fusion.

Authors:  Yorgo Modis; Steven Ogata; David Clements; Stephen C Harrison
Journal:  Nature       Date:  2004-01-22       Impact factor: 49.962

5.  Phylogenetic relationships and differential selection pressures among genotypes of dengue-2 virus.

Authors:  S Susanna Twiddy; Jeremy J Farrar; Nguyen Vinh Chau; Bridget Wills; Ernest A Gould; Tamara Gritsun; Graham Lloyd; Edward C Holmes
Journal:  Virology       Date:  2002-06-20       Impact factor: 3.616

6.  A ligand-binding pocket in the dengue virus envelope glycoprotein.

Authors:  Yorgo Modis; Steven Ogata; David Clements; Stephen C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-20       Impact factor: 11.205

7.  An outbreak of dengue virus at Rio de Janeiro--1986.

Authors:  H G Schatzmayr; R M Nogueira; A P Travassos da Rosa
Journal:  Mem Inst Oswaldo Cruz       Date:  1986 Apr-Jun       Impact factor: 2.743

8.  Dengue virus type 3, Brazil, 2002.

Authors:  Rita Maria Ribeiro Nogueira; Hermann Gonçalves Schatzmayr; Ana Maria Bispo de Filippis; Flávia Barreto dos Santos; Rivaldo Venâncio da Cunha; Janice Oliveira Coelho; Luiz José de Souza; Flávia Ramos Guimarães; Eliane Saraiva Machado de Araújo; Thatiane Santos De Simone; Meri Baran; Gualberto Teixeira; Marize Pereira Miagostovich
Journal:  Emerg Infect Dis       Date:  2005-09       Impact factor: 6.883

  8 in total
  29 in total

1.  Factors associated with dengue mortality in Latin America and the Caribbean, 1995-2009: an ecological study.

Authors:  Fredi Alexander Díaz-Quijano; Eliseu Alves Waldman
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

2.  Phylogenetic characterization of Dengue virus type 2 in Espírito Santo, Brazil.

Authors:  Raquel Spinassé Dettogni; Iúri Drumond Louro
Journal:  Mol Biol Rep       Date:  2011-05-12       Impact factor: 2.316

3.  Dengue dynamics and vaccine cost-effectiveness in Brazil.

Authors:  David P Durham; Martial L Ndeffo Mbah; Jan Medlock; Paula M Luz; Lauren A Meyers; A David Paltiel; Alison P Galvani
Journal:  Vaccine       Date:  2013-06-20       Impact factor: 3.641

4.  Comparative analysis of liver involvement caused by two DENV-2 lineages using an immunocompetent murine model.

Authors:  Fernanda Cunha Jácome; Gabriela Cardoso Caldas; Arthur da Costa Rasinhas; Ana Luisa Teixeira de Almeida; Daniel Dias Coutinho de Souza; Amanda Carlos Paulino; Raphael Leonardo; Ortrud Monika Barth; Flavia Barreto Dos Santos; Débora Ferreira Barreto-Vieira
Journal:  Sci Rep       Date:  2021-05-06       Impact factor: 4.379

5.  Origin and evolution of dengue virus type 3 in Brazil.

Authors:  Josélio Maria Galvão de Araújo; Gonzalo Bello; Hector Romero; Rita Maria Ribeiro Nogueira
Journal:  PLoS Negl Trop Dis       Date:  2012-09-06

6.  Cost-effectiveness of novel system of mosquito surveillance and control, Brazil.

Authors:  Kim M Pepin; Cecilia Marques-Toledo; Luciano Scherer; Maira M Morais; Brett Ellis; Alvaro E Eiras
Journal:  Emerg Infect Dis       Date:  2013-04       Impact factor: 6.883

7.  Characterization of Dengue virus type 2: new insights on the 2010 Brazilian epidemic.

Authors:  Camila Malta Romano; Andréia Manso de Matos; Evaldo Stanislau A Araújo; Lucy Santos Villas-Boas; Wanessa Cardoso da Silva; Olímpia M N P F Oliveira; Karina I Carvalho; Ana Carolina Mamana de Souza; Celia L Rodrigues; José Eduardo Levi; Esper G Kallas; Claudio Sergio Pannuti
Journal:  PLoS One       Date:  2010-07-28       Impact factor: 3.240

8.  Change in age pattern of persons with dengue, northeastern Brazil.

Authors:  Luciano P Cavalcanti; Dina Vilar; Reinaldo Souza-Santos; Maria G Teixeira
Journal:  Emerg Infect Dis       Date:  2011-01       Impact factor: 6.883

9.  Circulation of different lineages of Dengue virus 2, genotype American/Asian in Brazil: dynamics and molecular and phylogenetic characterization.

Authors:  Betânia Paiva Drumond; Adriano Mondini; Diane J Schmidt; Roberta Vieira de Morais Bronzoni; Irene Bosch; Maurício Lacerda Nogueira
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

10.  Twenty years of DENV-2 activity in Brazil: molecular characterization and phylogeny of strains isolated from 1990 to 2010.

Authors:  Nieli Rodrigues da Costa Faria; Rita Maria Ribeiro Nogueira; Ana Maria Bispo de Filippis; Jaqueline Bastos Santos Simões; Fernanda de Bruycker Nogueira; Monique da Rocha Queiroz Lima; Flavia Barreto dos Santos
Journal:  PLoS Negl Trop Dis       Date:  2013-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.